Cyp26b1 regulates retinoic acid-dependent signals in T cells and its expression is inhibited by transforming growth factor-β

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Takeuchi, Hajime ^a,b   Yokota, Aya ^a,b   Ohoka, Yoshiharu ^a,b   Iwata, Makoto ^a,b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR9; CYTOCHROME P450; CYTOCHROME P450 26B1; HERMES ANTIGEN; RETINOIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; RETINOIC ACID 4 HYDROXYLASE; RETINOIC ACID 4-HYDROXYLASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; GENE OVEREXPRESSION; GENE SILENCING; IN VITRO STUDY; INHIBITION KINETICS; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VITAMIN METABOLISM; ANIMAL; CELL DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; INTESTINES; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 79251587766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016089     Document Type: Article

References (46)

1. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, et al. (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538.
2. Iwata M (2009) Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin Immunol 21: 8-13.
3. Mora JR, Iwata M, Eksteen B, Song SY, Junt T, et al. (2006) Generation of guthoming IgA-secreting B cells by intestinal dendritic cells. Science 314: 1157-1160.
4. Yokota A, Takeuchi H, Maeda N, Ohoka Y, Kato C, et al. (2009) GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int Immunol 21: 361-377.
5. Ohoka Y, Yokota A, Takeuchi H, Maeda N, Iwata M (2011) Retinoic acidinduced CCR9 expression requires transient TCR stimulation and cooperativity between NFATc2 and the retinoic acid receptor/retinoid X receptor complex. J Immunol In press.
6. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
7. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, et al. (2007) A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-b and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
8. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774.
9. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785.
10. Schambach F, Schupp M, Lazar MA, Reiner SL (2007) Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17- secreting T helper cell differentiation. Eur J Immunol 37: 2396-2399.
11. Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH (2007) Vitamin A metabolites induce gut-homing FoxP3 + regulatory T cells. J Immunol 179: 3724-3733.
12. Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R (1996) Retinoids and Hox genes. FASEB J 10: 969-978.
13. Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, et al. (2006) Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 14: 4323-4340.
14. Marchetti MN, Sampol E, Bun H, Scoma H, Lacarelle B, et al. (1997) In vitro metabolism of three major isomers of retinoic acid in rats. Intersex and interstrain comparison. Drug Metab Dispos 25: 637-646.
15. Fujii H, Sato T, Kaneko S, Gotoh O, Fujii-Kuriyama Y, et al. (1997) Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. Embo J 16: 4163-4173.
16. MacLean G, Abu-Abed S, Dolle P, Tahayato A, Chambon P, et al. (2001) Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 107: 195-201.
17. Tahayato A, Dolle P, Petkovich M (2003) Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr Patterns 3: 449-454.
18. Yashiro K, Zhao X, Uehara M, Yamashita K, Nishijima M, et al. (2004) Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev Cell 6: 411-422.
19. Abu-Abed S, Dolle P, Metzger D, Beckett B, Chambon P, et al. (2001) The retinoic acid- etabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 15: 226-240.
20. Sakai Y, Meno C, Fujii H, Nishino J, Shiratori H, et al. (2001) The retinoic acidinactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev 15: 213-225.
21. Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, et al. (2008) Small intestinal CD103 + dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 205: 2139-2149.
22. Marill J, Cresteil T, Lanotte M, Chabot GG (2000) Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 58: 1341-1348.
23. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, et al. (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361: 1336-1343.
24. Bruynseels J, De Coster R, Van Rooy P, Wouters W, Coene MC, et al. (1990) R 75251, a new inhibitor of steroid biosynthesis. Prostate 16: 345-357.
25. Cantorna MT, Nashold FE, Hayes CE (1994) In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152: 1515-1522.
26. Stephensen CB, Rasooly R, Jiang X, Ceddia MA, Weaver CT, et al. (2002) Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol 168: 4495-4503.
27. Iwata M, Eshima Y, Kagechika H (2003) Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15: 1017-1025.
28. Dawson HD, Collins G, Pyle R, Key M, Weeraratna A, et al. (2006) Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol 7: 27.
29. Abu-Abed SS, Beckett BR, Chiba H, Chithalen JV, Jones G, et al. (1998) Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor c and retinoid X receptor a. J Biol Chem 273: 2409-2415.
30. Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, et al. (2004) A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and alltrans isomers of retinoic acid. J Biol Chem 279: 77-85.
31. Ozpolat B, Mehta K, Tari AM, Lopez-Berestein G (2002) All-trans-Retinoic acidinduced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. Am J Hematol 70: 39-47.
32. Marikar Y, Wang Z, Duell EA, Petkovich M, Voorhees JJ, et al. (1998) Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J Invest Dermatol 111: 434-439.
33. Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M (2005) Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem J 392: 241-248.
34. Loudig O, Babichuk C, White J, Abu-Abed S, Mueller C, et al. (2000) Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol Endocrinol 14: 1483-1497.
35. Balmer JE, Blomhoff R (2005) A robust characterization of retinoic acid response elements based on a comparison of sites in three species. J Steroid Biochem Mol Biol 96: 347-354.
36. Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66: 606-630.
37. White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, et al. (1997) CDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 272: 18538-18541.
38. White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, et al. (2000) Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci U S A 97: 6403-6408.
39. Mahmood R, Flanders KC, Morriss-Kay GM (1992) Interactions between retinoids and TGF b s in mouse morphogenesis. Development 115: 67-74.
40. Mahmood R, Flanders KC, Morriss-Kay GM, (1995)The effects of retinoid status on TGF b expression during mouse embryogenesis. Anat Embryol (Berl) 192: 21-33.
41. Nugent P, Greene RM (1994) Interactions between the transforming growth factor beta (TGF b) and retinoic acid signal transduction pathways in murine embryonic palatal cells. Differentiation 58: 149-155.
42. Nugent P, Potchinsky M, Lafferty C, Greene RM (1995) TGF-b modulates the expression of retinoic acid-induced RAR-b in primary cultures of embryonic palate cells. Exp Cell Res 220: 495-500.
43. Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, et al. (2001) CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121: 246-254.
44. Rivera-Nieves J, Ho J, Bamias G, Ivashkina N, Ley K, et al. (2006) Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology 131: 1518-1529.
45. Brand S (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
46. Takeuchi H, Yokota A, Ohoka Y, Kagechika H, Kato C, et al. (2010) Efficient induction of CCR9 on T cells requires coactivation of retinoic acid receptors and retinoid X receptors (RXRs): exaggerated T Cell homing to the intestine by RXR activation with organotins. J Immunol 185: 5289-5299.